{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:11:37Z","timestamp":1789398697077,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fondazione Periplo"},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15376-2","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T08:24:37Z","timestamp":1764059077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of comorbidities on survival in melanoma patients"],"prefix":"10.1186","volume":"26","author":[{"given":"Alessandra","family":"Buja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fortunato","family":"Cassalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Rugge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Trevisiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Zorzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Del Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Pantaleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Riccardo","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierfranco","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Belloni Fortina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Mocellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"15376_CR1","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jaad.2024.09.035","volume":"92","author":"Y Sun","year":"2025","unstructured":"Sun Y, Shen Y, Liu Q, Zhang H, Jia L, Chai Y, et al. Global trends in melanoma burden: a comprehensive analysis from the Global Burden of Disease Study, 1990\u20132021. J Am Acad Dermatol. 2025;92:100\u20137. https:\/\/doi.org\/10.1016\/j.jaad.2024.09.035.","journal-title":"J Am Acad Dermatol"},{"key":"15376_CR2","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/bjd\/ljae296","volume":"191","author":"D Lindsay","year":"2024","unstructured":"Lindsay D, Bell KJL, Olsen CM, Whiteman DC, Pathirana T, Collins LG. Estimating the magnitude and healthcare costs of melanoma in situ and thin invasive melanoma overdiagnosis in Australia. Br J Dermatol. 2024;191:906\u201313. https:\/\/doi.org\/10.1093\/bjd\/ljae296.","journal-title":"Br J Dermatol"},{"key":"15376_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","volume":"158","author":"M Arnold","year":"2022","unstructured":"Arnold M, Singh D, Laversanne M, Vignat J, Vaccarella S, Meheus F, et al. Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatol. 2022;158:495\u2013503. https:\/\/doi.org\/10.1001\/jamadermatol.2022.0160.","journal-title":"JAMA Dermatol"},{"key":"15376_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1053\/j.seminoncol.2003.12.024","volume":"31","author":"R Yancik","year":"2004","unstructured":"Yancik R, Ries LAG. Cancer in older persons: an international issue in an aging world. Semin Oncol. 2004;31:128\u201336. https:\/\/doi.org\/10.1053\/j.seminoncol.2003.12.024.","journal-title":"Semin Oncol"},{"key":"15376_CR5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3322\/caac.21342","volume":"66","author":"D Sarfati","year":"2016","unstructured":"Sarfati D, Koczwara B, Jackson C. The impact of comorbidity on cancer and its treatment. CA Cancer J Clin. 2016;66:337\u201350. https:\/\/doi.org\/10.3322\/caac.21342.","journal-title":"CA Cancer J Clin"},{"key":"15376_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/ddg.14293","volume":"19","author":"J Weilandt","year":"2021","unstructured":"Weilandt J, Diehl K, Schaarschmidt M-L, Kiecker F, Sasama B, Pronk M, et al. Patient preferences for treatment of advanced melanoma: impact of comorbidities. J Dtsch Dermatol Ges. 2021;19:58\u201370. https:\/\/doi.org\/10.1111\/ddg.14293.","journal-title":"J Dtsch Dermatol Ges"},{"key":"15376_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/CMR.0b013e328329fe95","volume":"19","author":"A Testori","year":"2009","unstructured":"Testori A, Soteldo J, Sances D, Mazzarol G, Trifir\u00f2 G, Zonta M, et al. Cutaneous melanoma in the elderly. Melanoma Res. 2009;19:125\u201334. https:\/\/doi.org\/10.1097\/CMR.0b013e328329fe95.","journal-title":"Melanoma Res"},{"key":"15376_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/bjc.2013.246","volume":"109","author":"AF Grann","year":"2013","unstructured":"Grann AF, Fr\u00f8slev T, Olesen AB, Schmidt H, Lash TL. The impact of comorbidity and stage on prognosis of Danish melanoma patients, 1987\u20132009: a registry-based cohort study. Br J Cancer. 2013;109:265\u201371. https:\/\/doi.org\/10.1038\/bjc.2013.246.","journal-title":"Br J Cancer"},{"key":"15376_CR9","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1093\/jnci\/djae163","volume":"116","author":"W Chen","year":"2024","unstructured":"Chen W, Altshuler RD, Daschner P, Salvador Morales C, St Germain DC, Guida J, et al. Older adults with cancer and common comorbidities-challenges and opportunities in improving their cancer treatment outcomes. J Natl Cancer Inst. 2024;116:1730\u20138. https:\/\/doi.org\/10.1093\/jnci\/djae163.","journal-title":"J Natl Cancer Inst"},{"key":"15376_CR10","unstructured":"OECD. Ageing and long-term care. In: Health Glance 2023 OECD Indicators, Paris: OECD Publishing. 2023. Available from: https:\/\/www.oecd.org\/en\/publications\/health-at-a-glance-2023_7a7afb35-en\/full-report\/component-81.html. Accessed 9 Apr 2025."},{"key":"15376_CR11","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.ejso.2016.01.010","volume":"42","author":"MJ Rees","year":"2016","unstructured":"Rees MJ, Liao H, Spillane J, Speakman D, McCormack C, Donahoe S, et al. Localized melanoma in older patients, the impact of increasing age and comorbid medical conditions. Eur J Surg Oncol. 2016;42:1359\u201366. https:\/\/doi.org\/10.1016\/j.ejso.2016.01.010.","journal-title":"Eur J Surg Oncol"},{"key":"15376_CR12","unstructured":"Guzzinati S, Zorzi M, Rossi CR, Buja A, Italiano I, Fiore AR, et al. High resolution registry of melanoma and care pathways monitoring in the Veneto Region, Italy. Data linkage and cancer registries . Copenhagen, Denmark: 2018. Available from: https:\/\/www.registrotumoriveneto.it\/english\/publications\/meetings\/posters\/2018-posters\/high-resolution-registry-of-melanoma-and-care-pathways-monitoring-in-the-veneto-region-italy\/.\u00a0Accessed 9 Apr 2025."},{"key":"15376_CR13","doi-asserted-by":"publisher","first-page":"1267534","DOI":"10.3389\/fpubh.2023.1267534","volume":"11","author":"A Buja","year":"2023","unstructured":"Buja A, De Luca G, Zorzi M, Bovo E, Mocellin S, Trevisiol C, et al. Thirty-two-year trends of cancer incidence by sex and cancer site in the Veneto region from 1987 to 2019. Front Public Health. 2023;11:1267534. https:\/\/doi.org\/10.3389\/fpubh.2023.1267534.","journal-title":"Front Public Health"},{"key":"15376_CR14","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3322\/caac.21409","volume":"67","author":"JE Gershenwald","year":"2017","unstructured":"Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67:472\u201392. https:\/\/doi.org\/10.3322\/caac.21409.","journal-title":"CA Cancer J Clin"},{"key":"15376_CR15","doi-asserted-by":"publisher","first-page":"e0279415","DOI":"10.1371\/journal.pone.0279415","volume":"17","author":"S Guzzinati","year":"2022","unstructured":"Guzzinati S, Battagello J, Bovo E, Baracco M, Baracco S, Carpin E, et al. Quality control on digital cancer registration. PLoS One. 2022;17:e0279415. https:\/\/doi.org\/10.1371\/journal.pone.0279415.","journal-title":"PLoS One"},{"key":"15376_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/9780470567333","volume-title":"Latent Class and Latent Transition Analysis: With Applications in the Social, Behavioral, and Health Sciences","author":"LM Collins","year":"2009","unstructured":"Collins LM, Lanza ST. Latent Class and Latent Transition Analysis: With Applications in the Social, Behavioral, and Health Sciences. 1st ed. John Wiley & Sons, Ltd; 2009. https:\/\/doi.org\/10.1002\/9780470567333.","edition":"1st ed"},{"key":"15376_CR17","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1200\/JCO.2009.27.0579","volume":"28","author":"SK Pal","year":"2010","unstructured":"Pal SK, Hurria A. Impact of age, sex, and comorbidity on cancer therapy and disease progression. J Clin Oncol. 2010;28:4086\u201393. https:\/\/doi.org\/10.1200\/JCO.2009.27.0579.","journal-title":"J Clin Oncol"},{"key":"15376_CR18","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1158\/0008-5472.CAN-22-1336","volume":"83","author":"CEJ Vrinzen","year":"2023","unstructured":"Vrinzen CEJ, Delfgou L, Stadhouders N, Hermens RPMG, Merkx MAW, Bloemendal HJ, et al. A systematic review and multilevel regression analysis reveals the comorbidity prevalence in cancer. Cancer Res. 2023;83:1147\u201357. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-1336.","journal-title":"Cancer Res"},{"key":"15376_CR19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.23736\/S2784-8671.21.07089-4","volume":"157","author":"AE El-Qushayri","year":"2022","unstructured":"El-Qushayri AE, Benmelouka AY, Salman S, Nardone B. Melanoma and hypertension: is there an association? A USA population-based study. Ital J Dermatol Venereol. 2022;157:270\u20134. https:\/\/doi.org\/10.23736\/S2784-8671.21.07089-4.","journal-title":"Ital J Dermatol Venereol"},{"key":"15376_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00520-022-07479-4","volume":"31","author":"M Obeng-Kusi","year":"2022","unstructured":"Obeng-Kusi M, Vardy JL, Bell ML, Choi BM, Axon DR. Comorbidities and perceived health status in persons with history of cancer in the USA. Support Care Cancer. 2022;31:16. https:\/\/doi.org\/10.1007\/s00520-022-07479-4.","journal-title":"Support Care Cancer"},{"key":"15376_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14537","volume":"34","author":"S Patel","year":"2021","unstructured":"Patel S, Cadwell JB, Ahsanuddin S, Lambert WC. Comparison of mortality and medical complications between older and younger malignant melanoma inpatients. Dermatol Ther. 2021;34:e14537. https:\/\/doi.org\/10.1111\/dth.14537.","journal-title":"Dermatol Ther"},{"key":"15376_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.846760","volume":"12","author":"C-K Chang","year":"2022","unstructured":"Chang C-K, Hsieh Y-S, Chen P-N, Chu S-C, Huang J-Y, Wang Y-H, et al. A cohort study: comorbidity and stage affected the prognosis of melanoma patients in Taiwan. Front Oncol. 2022;12:846760. https:\/\/doi.org\/10.3389\/fonc.2022.846760.","journal-title":"Front Oncol"},{"key":"15376_CR23","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.1245\/s10434-020-09224-9","volume":"28","author":"J Bogach","year":"2021","unstructured":"Bogach J, Wright FC, Austin J, Cheng SY, Diong C, Sutradhar R, et al. Medical immunosuppression and outcomes in cutaneous melanoma: a population-based cohort study. Ann Surg Oncol. 2021;28:3302\u201311. https:\/\/doi.org\/10.1245\/s10434-020-09224-9.","journal-title":"Ann Surg Oncol"},{"key":"15376_CR24","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.jaad.2022.11.043","volume":"88","author":"MA Kreher","year":"2023","unstructured":"Kreher MA, Konda S, Noland MMB, Longo MI, Valdes-Rodriguez R. Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part II: methotrexate, alkylating agents, biologics, and small molecule inhibitors. J Am Acad Dermatol. 2023;88:534\u201342. https:\/\/doi.org\/10.1016\/j.jaad.2022.11.043.","journal-title":"J Am Acad Dermatol"},{"key":"15376_CR25","first-page":"16","volume":"12","author":"FN Bebe","year":"2019","unstructured":"Bebe FN, Hu S, Brown TL, Tulp OL. Role, extent, and impact of comorbidity on prognosis and survival in advanced metastatic melanoma: a review. J Clin Aesthet Dermatol. 2019;12:16\u201323.","journal-title":"J Clin Aesthet Dermatol"},{"key":"15376_CR26","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jgo.2018.01.001","volume":"9","author":"MJ Rees","year":"2018","unstructured":"Rees MJ, Liao H, Spillane J, Speakman D, McCormack C, Donahoe S, et al. Melanoma in the very elderly, management in patients 85years of age and over. J Geriatr Oncol. 2018;9:488\u201393. https:\/\/doi.org\/10.1016\/j.jgo.2018.01.001.","journal-title":"J Geriatr Oncol"},{"key":"15376_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jaad.2021.12.066","volume":"87","author":"M Perez","year":"2022","unstructured":"Perez M, Abisaad JA, Rojas KD, Marchetti MA, Jaimes N. Skin cancer: primary, secondary, and tertiary prevention. Part I. J Am Acad Dermatol. 2022;87:255\u201368. https:\/\/doi.org\/10.1016\/j.jaad.2021.12.066.","journal-title":"J Am Acad Dermatol"},{"key":"15376_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jaad.2022.01.053","volume":"87","author":"KD Rojas","year":"2022","unstructured":"Rojas KD, Perez ME, Marchetti MA, Nichols AJ, Penedo FJ, Jaimes N. Skin cancer: primary, secondary, and tertiary prevention. Part II. J Am Acad Dermatol. 2022;87:271\u201388. https:\/\/doi.org\/10.1016\/j.jaad.2022.01.053.","journal-title":"J Am Acad Dermatol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15376-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15376-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15376-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T17:15:56Z","timestamp":1767633356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15376-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15376"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15376-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study involving human participants was conducted in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Italian legislation identifies cancer registries as collectors of personal data for surveillance purposes, with no need to obtain individuals\u2019 explicit informed consent [REF:\n                      \n                      ].This study project was formally approved by the Ethics Committee of the Veneto Oncological Institute (protocol number 52\/2016).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ABF received Consulting fees, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events, Support for attending meetings and\/or travel, and Participation on a Data Safety Monitoring Board or Advisory Board and from Sanofi, Abbvie, Leopharma, Pfizer, and Incyte. No other authors report any conflicts. The authors declare that this study was designed and conducted in the absence of any financial or commercial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}